Insider Trading activities of Xtent Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xtent Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xtent Inc since year 2005. Table 2 shows the detailed insider transactions of Xtent Inc since 2005. The reporting company's ticker symbol is XTNT. The reporting company's CIK number is 1212235.
The total value of stock buying since 2005 is $432,000.
The total value of stock sales since 2005 is $674,541.
The total value of stock option exercises since 2005 is $11,000.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Xtent Inc (XTNT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-10 0 $0 5,000 $6,680 0 $0
2008-09 0 $0 5,000 $10,100 0 $0
2008-08 0 $0 3,500 $8,967 0 $0
2008-07 0 $0 3,500 $8,505 10,000 $4,000
2008-06 0 $0 3,500 $12,127 0 $0
2008-05 0 $0 3,500 $12,250 0 $0
2008-04 0 $0 17,500 $83,475 1,000 $3,500
2008-03 0 $0 11,500 $81,264 1,000 $3,500
2008-02 0 $0 10,500 $101,078 0 $0
2008-01 0 $0 14,000 $138,401 0 $0
2007-12 0 $0 5,200 $48,983 0 $0
2007-11 0 $0 7,000 $70,056 0 $0
2007-10 0 $0 7,000 $64,802 0 $0
2007-09 0 $0 3,500 $27,853 0 $0
2007-02 27,000 $432,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Xtent Inc insiders (XTNT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-10-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 5,000 1.34 6,680
2008-09-02 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 5,000 2.02 10,100
2008-08-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 2.56 8,967
2008-07-18 Walsh Brian J (Other) Option Ex 10,000 .40 4,000
2008-07-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 2.43 8,505
2008-06-02 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 3.46 12,127
2008-05-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 3.50 12,250
2008-04-24 Walsh Brian J (VP-Sales & Marketing) Sale 3,000 4.12 12,375
2008-04-23 Walsh Brian J (VP-Sales & Marketing) Sale 3,000 4.55 13,655
2008-04-02 Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) Sale 3,000 4.94 14,820
2008-04-01 Kahlenberg Timothy D (Chief Financial Officer) Sale 1,000 5.02 5,025
2008-04-01 Kahlenberg Timothy D (Chief Financial Officer) Option Ex 1,000 3.50 3,500
2008-04-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 5.00 17,500
2008-04-01 Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) Sale 2,000 5.02 10,050
2008-04-01 Casciaro Gregory D (President and CEO) Sale 2,000 5.02 10,050
2008-03-03 Kahlenberg Timothy D (Chief Financial Officer) Sale 1,000 7.11 7,113
2008-03-03 Kahlenberg Timothy D (Chief Financial Officer) Option Ex 1,000 3.50 3,500
2008-03-03 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 7.05 24,682
2008-03-03 Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) Sale 5,000 7.07 35,335
2008-03-03 Casciaro Gregory D (President and CEO) Sale 2,000 7.07 14,134
2008-02-04 Casciaro Gregory D (President and CEO) Sale 2,000 9.78 19,550
2008-02-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 9.65 33,778
2008-02-01 Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) Sale 5,000 9.55 47,750
2008-01-25 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 7,000 10.02 70,154
2008-01-03 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 1,400 9.11 12,748
2008-01-02 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 2,100 9.72 20,422
2007-12-26 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 1,700 10.00 17,000
2007-12-06 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 9.14 31,983
2007-11-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 7,000 10.01 70,056
2007-10-18 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 10.01 35,035
2007-10-01 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 8.50 29,767
2007-09-04 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) Sale 3,500 7.96 27,853
2007-02-06 Bellas Robert C Jr (Director) Buy 25,000 16.00 400,000
2007-02-06 Flaherty Robert E (Director) Buy 2,000 16.00 32,000

Insider trading activities including stock purchases, stock sales, and option exercises of XTNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xtent Inc (symbol XTNT, CIK number 1212235) see the Securities and Exchange Commission (SEC) website.